U.S. Patent on Cytori Therapeutics, Inc.'s Celution® System Technology Issued; Celution® System Commercialization not Impacted by Recent 6,777,231 Patent Inventorship Decision

SAN DIEGO--(BUSINESS WIRE)--U.S. Patent No. 7,390,484 (“the ‘484 patent”) covering Cytori’s (NASDAQ:CYTX) Celution® System technology was issued today by the United States Patent and Trademark Office. The ‘484 patent provides Cytori critical market protection for its commercialization of the Celution System in the United States, where the Company is seeking regulatory approval. The ‘484 patent also protects Cytori’s rights to manufacture the Celution Systems in the United States for commercialization into all markets, including Europe and Asia-Pacific, where the device is currently being sold. Other related patent filings are in progress around the globe.

MORE ON THIS TOPIC